AI-generated summary
The authors randomly assigned 60 rhinoplasty candidates to two groups and tested photobiomodulation on the first postoperative day, using red light at 660 nm, infrared light at 840 nm, and an infrared laser. They report that the low-power laser significantly reduced periorbital ecchymosis, and they state that photobiomodulation may be effectively used for this purpose.
- Participants
- 60
- Who or what was studied
- Rhinoplasty candidates
- Wavelengths
- 660, 840 nm
- Limits stated in the abstract
- The abstract does not describe the control arm or blinding details beyond the label single-blind, and it provides no effect size or confidence interval.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 840 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Randomized controlled trial, Photobiomodulation therapy, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.